Agrowingbodyof evidence supports the association between sleep and circadian function and AD risk. A tsunami of AD looms in the coming 20 to 30 years, and sleep and circadian therapies that reduce AD risk would benefit societal health. To achieve such a goal,researchers in this area must intentionally adopt strategies to translate science efficiently and collaboratively into clinical trials and public implementation.

Original languageEnglish
Pages (from-to)835-836
Number of pages2
JournalJAMA Neurology
Issue number9
StatePublished - Sep 2022


Dive into the research topics of 'Targeting Sleep and Circadian Function in the Prevention of Alzheimer Disease'. Together they form a unique fingerprint.

Cite this